Skip to main content

KOD Kodiak Sciences Inc.

Healthcare

94.26

Close 10/8

Open
90.01
High
94.95
Low
89.54
Prev close
91.08
Volume
1.5M
P/B
97.0
52W 10.94 104.00
Loading candles…

Is Kodiak Sciences Inc. a buy? Fundamentals and valuation first

As of 2026-10-08

Growth: Good, Momentum: Strong; Valuation: Expensive, Quality: Weak.

Valuation Expensive Free-cash-flow yield is Average; Price / book is Expensive.
TTM P/E -22.5 N/A
Price / book 96.97 99th percentile Expensive
Free-cash-flow yield (%) -2.7 34th percentile Average
Quality Weak ROE, TTM is Lagging.
ROE, TTM (%) -396.09 3th percentile Lagging
Operating margin, TTM (%) — N/A
FCF margin, TTM (%) — N/A
Growth Good Diluted EPS growth, TTM YoY is Good.
Revenue growth, TTM YoY (%) — N/A
Diluted EPS growth, TTM YoY (%) 10.26 62th percentile Good
Momentum Strong All 2 indicators are Top.
60-day return (%) 122.21 99th percentile Top
240-day return (%) 450.91 100th percentile Top
Risk / liquidity Neutral 20-day dollar volume is Top, but 60-day annualized volatility is Expensive.
20-day dollar volume 308,419,419 95th percentile Top
60-day annualized volatility (%) 368.9 98th percentile Expensive

Kodiak Sciences Inc. (KOD) today

1 quant signals active · As of 2026-10-08

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

Kodiak Sciences Inc. (KOD) peers and tracking

Watchlist

This page refreshes daily after the close. Add Kodiak Sciences Inc. to your watchlist to track signal changes on your next visit.

Kodiak Sciences Inc. (KOD) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 96.68%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

13 historical occurrences (since 2019-05-24)
Average forward return after Top-quintile 6-month momentum。20-day: Win 58.3%, Sample 12, Median +8.06%, Excess +9.08%, Beat mkt rate 50%；60-day: Win 50%, Sample 12, Median +4.26%, Excess +7.1%, Beat mkt rate 50%；120-day: Win 45.5%, Sample 11, Median -22.76%, Excess +32.93%, Beat mkt rate 45.5%

120 days after: historical avg +41.73%

20-day +11.73%
60-day +12.24%
120-day +41.73%
20-day
60-day
120-day
Win
58.3%
50%
45.5%
Sample
12
12
11
Median
+8.06%
+4.26%
-22.76%
Excess
+9.08%
+7.1%
+32.93%
Beat mkt rate
50%
50%
45.5%

Over 11 occurrences, 120-day forward avg gained 41.73%, beat the market by 32.93 pts; win rate 45.5%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 98,247 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.22%, a 57.8% positive-return rate, and +2.87 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

11 times historically; 60-day forward avg +48.48%, win rate 60%, beating the market by +42.91 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

9 times historically; 60-day forward avg +51.24%, win rate 77.8%, beating the market by +44.75 pts on average.

Continue researching Kodiak Sciences Inc. with the evidence above.

Continue in Studio ↗

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.